Caroline Green

at Creative BioMart

Caroline represents Creative BioMart, a biotech company based in New York, providing quality GMP proteins, recombinant proteins, and other protein products to the research community of biology, clinical research, molecular diagnostics, and biopharmaceutical drug development.

Contributing Author in
Novel Therapeutics

Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.

Latest articles from Caroline

New Study Shows Remdesivir Prevents Coronavirus MERS-CoV Infection In Monkeys

In a new study, researchers from the National Institutes of Health reported that the experimental antiviral drug remdesivir (also known as GS-5734) successfully prevented rhesus monkeys infected with the Middle East Respiratory Syndrome (MERS) coronavirus (MERS-CoV) from becoming ill from …

This Discovery Of Immune Cells May Start The Development Of New Anti-cancer Therapies

Recently, in research published in the Immunity, researchers from University College London in the United Kingdom revealed that a special type of immune cells can be activated to kill cancerous cells through research on mice. Related research may give …

The Key Role Of Stem Cells In Lethal Gastric Cancer Revealed

In a recent study published in Nature Communications, scientists from Cornell University made new findings in common and fatal gastric cancer research. In the United States, the incidence of gastroesophageal cancer increased 2.5-fold from the 1970s to the early …